AI blood test could spot deadly clotting complication in sepsis patients

NCT ID NCT07630415

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to validate a new blood test that uses artificial intelligence to detect disseminated intravascular coagulation (DIC) early in patients with septic shock. DIC is a severe clotting disorder that often leads to death, but current diagnostic methods are complex and rarely used. The test measures a specific blood cell signal and combines it with AI to provide a faster, more reliable diagnosis. Researchers will enroll 492 adults in intensive care to see if this approach works better than existing tools.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
neutrophil fluorescence test and AI model
What this could lead to
If successful, this could give doctors a simple, fast blood test to catch a deadly complication of sepsis early, potentially saving lives.
What could go wrong
This is an early validation study, not a treatment trial. The test may not prove accurate enough in real-world intensive care settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISSEMINATED INTRAVASCULAR COAGULATION (DIC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The University Hospitals of Strasbourg, Intensive Care Medicine Department - New Civil Hospital

    Strasbourg, 67098, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.